A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.
Publication
, Conference
Whitley, MJ; Cardona, DM; Blazer, DG; Hwang, SE; Mosca, PJ; Cahill, J; Ferrer, JM; Strasfeld, DB; Mito, JK; Cuneo, KC; Larrier, N; Williams, N ...
Published in: Journal of Clinical Oncology
May 20, 2014
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2014
Volume
32
Issue
15_suppl
Start / End Page
TPS11135 / TPS11135
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Whitley, M. J., Cardona, D. M., Blazer, D. G., Hwang, S. E., Mosca, P. J., Cahill, J., … Brigman, B. E. (2014). A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015. In Journal of Clinical Oncology (Vol. 32, pp. TPS11135–TPS11135). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.tps11135
Whitley, Melodi Javid, Diana M. Cardona, Dan G. Blazer, Shelley E. Hwang, Paul J. Mosca, Joan Cahill, Jorge M. Ferrer, et al. “A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.” In Journal of Clinical Oncology, 32:TPS11135–TPS11135. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.tps11135.
Whitley MJ, Cardona DM, Blazer DG, Hwang SE, Mosca PJ, Cahill J, et al. A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. TPS11135–TPS11135.
Whitley, Melodi Javid, et al. “A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. TPS11135–TPS11135. Crossref, doi:10.1200/jco.2014.32.15_suppl.tps11135.
Whitley MJ, Cardona DM, Blazer DG, Hwang SE, Mosca PJ, Cahill J, Ferrer JM, Strasfeld DB, Mito JK, Cuneo KC, Larrier N, Williams N, Spasojevic I, Riedel RF, Eward W, Lee WD, Griffith LG, Bawendi M, Kirsch DG, Brigman BE. A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. TPS11135–TPS11135.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2014
Volume
32
Issue
15_suppl
Start / End Page
TPS11135 / TPS11135
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences